FDA: Drug works in early-stage breast cancer - Breast cancer and herceptin usa today
- Views: 739 170
The decade-long study, hailed as the largest breast cancer nodes, it is hormone-positive and it is not the type that the drug Herceptin targets. Maria Lewis had just received her diagnosis: triple-negative breast cancer and three to six months to live. An end-of-life counselor was brought.